ArticleTransplantation direct2024

Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry.

Christian P Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.